Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Medtronic
Dow
Colorcon
Boehringer Ingelheim

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for JZP-110

See Plans and Pricing

« Back to Dashboard

What is the drug development status for JZP-110?

JZP-110 is an investigational drug.

There have been 11 clinical trials for JZP-110. The most recent clinical trial was a Phase 1 trial, which was initiated on May 1st 2015.

The most common disease conditions in clinical trials are Narcolepsy, Disorders of Excessive Somnolence, and Sleep Apnea, Obstructive. The leading clinical trial sponsors are Jazz Pharmaceuticals, Children's Oncology Group (COG), and Concert Pharmaceuticals.

There are twenty-two US patents protecting this investigational drug and one hundred and sixty-three international patents.

Recent Clinical Trials for JZP-110
TitleSponsorPhase
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)Children's Oncology Group (COG)Phase 2/Phase 3
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)Jazz PharmaceuticalsPhase 2/Phase 3
A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety ExtensionJazz PharmaceuticalsPhase 3

See all JZP-110 clinical trials

Clinical Trial Summary for JZP-110

Top disease conditions for JZP-110
Top clinical trial sponsors for JZP-110

See all JZP-110 clinical trials

US Patents for JZP-110

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
JZP-110   Start Trial Formulations of (R)-2-amino-3-phenylpropyl carbamate Jazz Pharmaceuticals International III Limited (Hamilton, BM)   Start Trial
JZP-110   Start Trial Methods for treating attention-deficit/hyperactivity disorder SK Biopharmaceuticals Co., Ltd. (Seongnam-si, Gyeonggi-do, KR)   Start Trial
JZP-110   Start Trial Treatment of cataplexy Jazz Pharmaceuticals International III Limited (Hamilton, BM) SK Biopharmaceuticals Co., Ltd. (Seoul, KR)   Start Trial
JZP-110   Start Trial Aminocarbonylcarbamate compounds SK BIOPHARMACEUTICALS CO., LTD. (Seoul, KR)   Start Trial
JZP-110   Start Trial Methods for treating drug addiction and improving addiction-related behavior SK Biopharmaceuticals Co., Ltd. (Seoul, KR)   Start Trial
JZP-110   Start Trial Methods for treatment of sexual dysfunction SK Biopharmaceuticals Co., Ltd. (Seoul, KR)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for JZP-110

Drugname Country Document Number Estimated Expiration Related US Patent
JZP-110 Australia 2017324855 2036-09-06   Start Trial
JZP-110 Canada 3036068 2036-09-06   Start Trial
JZP-110 China 109906078 2036-09-06   Start Trial
JZP-110 European Patent Office 3509581 2036-09-06   Start Trial
JZP-110 Israel 265193 2036-09-06   Start Trial
JZP-110 Philippines 12019500494 2036-09-06   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Moodys
Baxter
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.